ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook

The following are excerpts from the newsletter



March 11, 2004

March 25, 2004

  • Intimidation: Practitioners speak up about this unresolved problem (Part II)
  • The recall on oxymetazoline nasal spray by CDC.
  • Confusion between BICILLIN products puts hundreds of patients at risk.
  • Child harmed with potassium chloride given IV push.
  • How to avoid confusion between PROTONIX (pantoprazole), PROTEINEX (protein hydrolisate), and protamine.
  • How to implement JC's prohibited abbreviation requirement.
  • How ISMP's alerts help avoid methotrexate errors.
  • More on difficulties with implantable pumps.

subscribe now

Resources
Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas - Free CEs
Special Error Alerts
Subscribe
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Long Term Care
Consumer
ISMP 17th Annual Cheers Awards
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2014 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP